CClinicalTrials.gg
CompletedNCT04819724LiTransUpdated Apr 12, 2024

Load-induced Changes in Glenohumeral Translation in Patients With Rotator Cuff Tear

An interventional study of 3D motion analysis and isometric shoulder strength by dynamometer in Rotator Cuff Tear, sponsored by University Hospital, Basel, Switzerland. Completed at 1 site in Switzerland. Open to participants aged 20 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-12.

Sponsored by University Hospital, Basel, Switzerland · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Non-randomized
Ages
20 Years to 85 Years
Sex
All
01

Study summary

The study is to investigate the dose-response relationship between load-induced muscle activation (liMA) and load-induced glenohumeral translation (liTr) in patients with rotator cuff tears and asymptomatic control subjects.

Furthermore the study is to investigate the in vivo dose-response relationship between additional weight and glenohumeral translation, to understand the biological variation in liTr, the influence of disease pathology on the liTr, the potential compensation by muscle activation and muscle size, and the influence of liTr on patient outcomes.

Read the detailed description

This project is to test the overall hypothesis that rotator cuff tear affects glenohumeral translation and that this functional instability depends on additional load applied, on anatomical and morphological variations, and on type and severity of the injury. The study is to investigate the dose-response relationship between load-induced muscle activation (liMA) and load-induced glenohumeral translation (liTr) in patients with rotator cuff tears and asymptomatic control subjects.

Furthermore the study is to investigate the in vivo dose-response relationship between additional weight and glenohumeral translation, to understand the biological variation in liTr, the influence of disease pathology on the liTr, the potential compensation by muscle activation and muscle size, and the influence of liTr on patient outcomes.

This study entails cross-sectional experimental multimodal (clinical, biomechanical, radiological) data collection with multiple conditions and a control group.

02

Conditions studied

  • Rotator Cuff Tear

Browse trials for

Keywords

  • glenohumeral translation
  • Load-induced Glenohumeral Translation (liTr )
  • Load-induced Muscle Activation (liMA)
03

In context

Rotator Cuff Injuries

734 studies on the registry are indexed under Rotator Cuff Injuries; 161 are open to participants now.

This study's enrollment of 75 is above the median of 60 across 538 interventional studies indexed under Rotator Cuff Injuries.

Browse Rotator Cuff Injuries studies →

Lead sponsor

University Hospital, Basel, Switzerland is the lead sponsor of 968 studies on the registry; 191 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

We will examine a cohort of 75 subjects:

  • Group 1: 25 patients with unilateral symptomatic rotator cuff tear between 45 and 85 years
  • Group 2: 25 asymptomatic control subjects (age and sex distribution matching the patient group) Group 3: 25 sex matched young asymptomatic control subjects between 20 and 30 years

Inclusion criteria patients:

  • Diagnosed unilateral rotator cuff tear
  • Partial or complete supraspinatus muscle tear
  • With or without injury to other rotator cuff muscles

Exclusion criteria patients:

  • Prior operative treatment of the ipsilateral shoulder or elbow
  • Clinical history or symptoms of the contralateral glenohumeral joint
  • Range of motion \<30° in abduction and flexion

Inclusion criteria asymptomatic control subjects:

  • No previous known elbow and shoulder injury or symptoms

Exclusion criteria asymptomatic control subjects:

  • Clinical history of the glenohumeral joint
  • Prior conservative or operative treatment of the shoulder or elbow
  • Range of motion \<90° in abduction and flexion

General exclusion criteria:

  • Inability to provide informed consent
  • Body mass index (BMI) > 35 kg/m2 (Excessive skin movement)
  • Neuromuscular disorders affecting upper limb movement
  • Additional pathologies that influence the mobility of the shoulder joints
  • Contraindications for MRI (e.g. neurostimulator and claustrophobia)
  • Prior neuromuscular impairment (e.g. stroke)
  • Diagnosed active rheumatic disorder
  • Other major medical problems
  • Pregnancy
  • Patients currently enrolled in another experimental (interventional) protocol
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
75 participants (actual)

Study arms

  • Other
    Group 1: patient group (unilateral rotator cuff tear)

    Group 1: 25 patients with unilateral symptomatic rotator cuff tear

    Diagnostic Test: 3D motion analysis · Diagnostic Test: isometric shoulder strength by dynamometer · Diagnostic Test: fluoroscopic images of each shoulder · Diagnostic Test: Bilateral shoulder Magnetic Resonance Imaging (MRI) · Other: data collection by health questionnaires

  • Other
    Group 2: control group (asymptomatic volunteers)

    Group 2: (asymptomatic volunteers) 25 asymptomatic control subjects (age and sex distribution matching the patient group)

    Diagnostic Test: 3D motion analysis · Diagnostic Test: isometric shoulder strength by dynamometer · Diagnostic Test: fluoroscopic images of each shoulder · Diagnostic Test: Bilateral shoulder Magnetic Resonance Imaging (MRI) · Other: data collection by health questionnaires

  • Other
    Group 2: young control group (young asymptomatic volunteers)

    Group 3: (young asymptomatic volunteers) 25 asymptomatic control subjects, 20 to 30 years (sex distribution matching the patient group)

    Diagnostic Test: 3D motion analysis · Diagnostic Test: isometric shoulder strength by dynamometer · Diagnostic Test: fluoroscopic images of each shoulder · Diagnostic Test: Bilateral shoulder Magnetic Resonance Imaging (MRI) · Other: data collection by health questionnaires

Interventions

  • Diagnostic test3D motion analysis

    30° arm abduction in the scapular plane will be performed with and without a handheld weight of 1, 2, 3, and 4 kg. All movements will be done bilaterally. Electromyographic (EMG) data of arm and trunk muscles will be recorded using surface electrodes. Participants will be asked to perform full arm abduction with different rotations (internal, neutral and external rotation), flexion and internal-/external rotations movements (without additional handheld weight).

  • Diagnostic testisometric shoulder strength by dynamometer

    isometric shoulder strength for abduction and internal/external rotation will be assessed with a isometric shoulder strength for abduction and internal/external rotation will be assessed with a dynamometer

  • Diagnostic testfluoroscopic images of each shoulder

    fluoroscopic images (Multitom Rax, Siemens Healthineers, Erlangen, Germany) of each shoulder will be taken during the 30° arm abduction test with and without a handheld weight (0, 2, and 4kg)

  • Diagnostic testBilateral shoulder Magnetic Resonance Imaging (MRI)

    MRI of both shoulders will be taken

  • Otherdata collection by health questionnaires

    data collection by health questionnaires

06

What researchers measure

Primary outcomes

  1. Disabilities of arm, shoulder and hand (Quick DASH) questionnaire

    30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale (1 being no difficulty, 5 being unable).

    Time frame: at baseline (approximate duration for all questionnaires: 20 minutes)

  2. Constant Score

    The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher the score, the higher the quality of the function.

    Time frame: at baseline (approximate duration for all questionnaires: 20 minutes)

  3. American Shoulder and Elbow Surgeons (ASES) Shoulder Score

    The American Shoulder and Elbow Surgeons Shoulder Score (ASES) is a mixed outcome reporting measure, applicable for use in all patients with shoulder pathology regardless of their specific diagnosis. The ASES questionnaire is composed of both a physician-rated component and a patient-reported component. The patient questions focus on joint pain, instability, and activities of daily living. The pain and functional portions are summed to obtain the final ASES score with higher scores indicating better outcomes.

    Time frame: at baseline (approximate duration for all questionnaires: 20 minutes)

  4. Subjective Shoulder Value (SSV)

    The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100%.

    Time frame: at baseline (approximate duration for all questionnaires: 20 minutes)

  5. numerical pain rating scale (NRS) score

    The Numeric Pain Rating Scale (NPRS) is a unidimensional measure of pain intensity in adults (from 0-10: "0" = no pain. "10" = the most intense pain imaginable)

    Time frame: at baseline (approximate duration for all questionnaires: 20 minutes)

  6. Loaded shoulder abduction test with motion analysis

    The subject will lift their arm to 30° shoulder abduction in the scapular plane, data will be captured holding 0, 1, 2, 3, and 4 kg, respectively, in their hand. Reflective surface markers will be placed bilaterally on the participants' trunk and arms. Position of these markers will be recorded using infrared cameras that only record the reflections of the markers. Additionally, inertial sensors will be positioned on the subjects' thorax, scapulae, humeri and forearms.

    Time frame: at baseline (approximate duration for motion analysis: 50 minutes)

  7. Loaded shoulder abduction test with single plane fluoroscopic images

    fluoroscopic images (Multitom Rax, Siemens Healthineers, Erlangen, Germany) of each shoulder will be taken during the 30° arm abduction test with and without a handheld weight (0, 2, and 4kg)

    Time frame: at baseline (approximate duration for motion analysis: 50 minutes).

  8. Load-induced muscle activity from electromyography (EMG)

    During arm movements in the loaded shoulder test and muscle strength tests, muscle activation of the infraspinatus, biceps brachii, anterior, middle and posterior part of the deltoid, clavicular part of the pectoralis major, latissimus dorsi and the upper part of the trapezius will be measured bilaterally using a 16-channel EMG system

    Time frame: at baseline (approximate duration for motion analysis: 50 minutes)

  9. Glenohumeral translation from single plane fluoroscopy

    the vertical distance of the glenohumeral joint centre (GHJC) and the radiopaque acromion marker will be measured. Fluoroscopy (FL) based liTr will be calculated for each participant as the slope of the regression of the negative GHJC to acromion distance measurements on the load magnitude.

    Time frame: at baseline (approximate duration for motion analysis: 50 minutes)

  10. Glenohumeral translation from instrumented motion analysis

    The vertical distance of the GHJC to the acromion marker will be calculated for a neutral trial and with the arm in 30° shoulder abduction for each loading condition. Motion analysis (MA) based liTr will be calculated for each participant as the slope of the regression of the negative GHJC to acromion distance measurements on the load magnitude

    Time frame: at baseline (approximate duration for motion analysis: 50 minutes)

  11. Critical shoulder angle (CSA)

    Subject's CSA will be measured on an anterior-posterior double-obliquity fluoroscopy image of the shoulder as the angle subtended by a line parallel to the glenoid and a line through the inferior-lateral edge of the glenoid and the inferior-lateral edge of the acromion. The CSA is reproducible and significantly greater in patients with rotator cuff tears than the general population. High angles (\>35°-38°) have been associated with rotator cuff tears and greater joint instability.

    Time frame: at baseline (approximate duration for motion analysis: 50 minutes)

  12. Glenoid inclination (GI)

    GI will be measured on the fluoroscopy image as the angle between a line from the upper to the lower glenoid rim (glenoid plane) and a second line set on the floor of the supraspinous fossa. Abnormal GI might be associated with rotator cuff tears and superior humeral head migration.

    Time frame: at baseline (approximate duration for motion analysis: 50 minutes)

  13. Greater tuberosity angle (GTA)

    GTA will be measured as the angle between a line parallel to the humerus diaphysis through the GHJC and a line from the upper border of the humeral head to the most superolateral edge of the greater tuberosity. A GTA of more than 70° has been observed to predict rotator cuff tear.

    Time frame: at baseline (approximate duration for motion analysis: 50 minutes)

  14. Muscle cross sectional area (MCSA)

    The MCSA of all rotator cuff muscles will be measured at two different positions on parasagittal reformatted images. MCSA of the deltoid will also be measured on the axial plane at the middle of the glenoid.

    Time frame: at baseline (approximate duration is approximately 1 hour and 15 minutes)

  15. Tear size retrieved from MR images

    Tear size will be classified into partial (1) or complete supraspinatus muscle tear (2).

    Time frame: at baseline (approximate duration is approximately 1 hour and 15 minutes)

  16. Tear type retrieved from MR images

    Tear type will be classified into supraspinatus tear without injury to other rotator cuff muscles (type A) and with injury to other rotator cuff muscles (type B). Both will be used as indicators for injury severity

    Time frame: at baseline (approximate duration is approximately 1 hour and 15 minutes)

  17. Isometric shoulder muscle strength for abduction and internal/external rotation

    Shoulder muscle strength will be tested under isometric conditions using a dynamometer. The maximum of 3 trials will be calculated and recorded as the participant's maximum isometric strength.

    Time frame: at baseline (approximate duration: 40 minutes).

07

Study locations

1 site
  • Department of Orthopaedics and Traumatology, University Hospital Basel
    Basel, 4031, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04819724
Lead sponsor
University Hospital, Basel, Switzerland
Collaborators
Swiss National Science Foundation
Responsible party
Sponsor
First posted
Mar 29, 2021
Start date
May 4, 2021
Primary completion
Dec 31, 2022
Completion
Dec 31, 2023
Last update
Apr 12, 2024

Study contacts

Annegret Mündermann, Prof. Dr.
principal investigator · Department of Orthopaedics and Traumatology, University Hospital Basel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion